UV1 Triple Combo Maintenance Therapy Will Be Tested in Phase 2 Trial
News
Ultimovacs will test its experimental cancer vaccine, UV1, as part of a triple-combination therapy for women with relapsed ovarian cancer who have no mutations in their BRCA DNA repair genes. ... Read more